Mar 28 |
Why Is Esperion Therapeutics (ESPR) Up 2% Since Last Earnings Report?
|
Mar 26 |
Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference
|
Mar 25 |
Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24
|
Mar 25 |
Esperion stock jumps 18% in wake of FDA label expansions
|
Mar 25 |
Why Is Heart Disease-Focused Esperion Therapeutics Stock Trading Higher On Monday?
|
Mar 25 |
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
|
Mar 22 |
U.S. FDA Approves Broad New Labels for Esperion’s NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
|
Mar 22 |
U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
|
Mar 22 |
CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events
|
Mar 5 |
11 Best Small Cap Pharma Stocks to Invest In
|